Compugen (CGEN) Current Assets (2009 - 2026)
Compugen recorded quarterly Current Assets of $137.3 million in Q1 2026, down 7.25% quarter-over-quarter from $148.0 million in Q4 2025.
Compugen's Current Assets history runs 11 years deep, the most recent figure standing at $137.3 million for Q1 2026.
- In Q1 2026, Current Assets changed N/A year-over-year to $137.3 million; the TTM figure through Mar 2026 stood at $137.3 million (changed N/A YoY), while the FY2025 annual figure was $148.0 million, up 39.65% from the prior year.
- Current Assets came in at $137.3 million for Q1 2026 at Compugen, down from $148.0 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $148.0 million in Q4 2025 to a low of $86.1 million in Q4 2022.
- A 5-year average of $118.4 million and a median of $114.6 million in 2023 frame the typical range for Current Assets.
- Across the five-year window, Current Assets slumped 30.11% in 2022 and jumped 39.65% in 2025, its largest moves.
- Compugen's Current Assets stood at $86.1 million in 2022, then soared by 33.04% to $114.6 million in 2023, then declined by 7.49% to $106.0 million in 2024, then surged by 39.65% to $148.0 million in 2025, then dropped by 7.25% to $137.3 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $137.3 million, $148.0 million, and $106.0 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 137.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 137.28 Mn |
| Dec 31, 2025 | 148.02 Mn |
| Sep 30, 2025 | 88.92 Mn |
| Jun 30, 2025 | 97.64 Mn |
| Mar 31, 2025 | 106.89 Mn |
| Dec 31, 2024 | 106.00 Mn |
| Sep 30, 2024 | 114.83 Mn |
| Jun 30, 2024 | 102.13 Mn |
| Mar 31, 2024 | 105.57 Mn |
| Dec 31, 2023 | 114.58 Mn |
| Sep 30, 2023 | 60.27 Mn |
| Jun 30, 2023 | 69.40 Mn |
| Mar 31, 2023 | 76.44 Mn |
| Dec 31, 2022 | 86.13 Mn |
| Sep 30, 2022 | 91.04 Mn |
| Jun 30, 2022 | 101.98 Mn |
| Mar 31, 2022 | 112.12 Mn |
| Dec 31, 2021 | 123.22 Mn |
| Sep 30, 2021 | 112.28 Mn |
| Jun 30, 2021 | 113.75 Mn |
| Mar 31, 2021 | 121.09 Mn |
| Dec 31, 2020 | 129.09 Mn |
| Sep 30, 2020 | 134.14 Mn |
| Jun 30, 2020 | 137.15 Mn |
| Mar 31, 2020 | 122.29 Mn |
| Dec 31, 2019 | 45.00 Mn |
| Sep 30, 2019 | 48.35 Mn |
| Jun 30, 2019 | 37.78 Mn |
| Mar 31, 2019 | 39.68 Mn |
| Dec 31, 2018 | 46.58 Mn |
| Sep 30, 2018 | 44.49 Mn |
| Jun 30, 2018 | 44.37 Mn |
| Mar 31, 2018 | 31.98 Mn |
| Dec 31, 2017 | 31.18 Mn |
| Sep 30, 2017 | 39.37 Mn |
| Jun 30, 2017 | 47.54 Mn |
| Mar 31, 2017 | 55.85 Mn |
| Dec 31, 2016 | 62.68 Mn |
| Sep 30, 2016 | 69.34 Mn |
| Jun 30, 2016 | 75.91 Mn |
| Mar 31, 2016 | 82.72 Mn |
| Dec 31, 2015 | 91.00 Mn |
| Sep 30, 2015 | 77.10 Mn |
| Jun 30, 2015 | 98.12 Mn |
| Mar 31, 2015 | 68.55 Mn |
| Dec 31, 2014 | 75.10 Mn |
| Sep 30, 2014 | 110.11 Mn |
| Jun 30, 2014 | 117.17 Mn |
| Mar 31, 2014 | 121.85 Mn |
| Dec 31, 2013 | 53.22 Mn |
| Sep 30, 2013 | 51.85 Mn |
| Jun 30, 2013 | 33.66 Mn |
| Mar 31, 2013 | 30.31 Mn |
| Dec 31, 2012 | 25.57 Mn |
| Sep 30, 2012 | 20.76 Mn |
| Jun 30, 2012 | 22.64 Mn |
| Mar 31, 2012 | 25.74 Mn |
| Dec 31, 2011 | 23.01 Mn |
| Sep 30, 2011 | 22.30 Mn |
| Jun 30, 2011 | 25.08 Mn |
| Mar 31, 2011 | 26.47 Mn |
| Dec 31, 2010 | 28.08 Mn |
| Sep 30, 2010 | 22.28 Mn |
| Jun 30, 2010 | 23.26 Mn |
| Mar 31, 2010 | 23.93 Mn |
| Dec 31, 2009 | 24.31 Mn |
| Sep 30, 2009 | 10.11 Mn |
| Jun 30, 2009 | 11.55 Mn |
| Mar 31, 2009 | 9.53 Mn |